| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| B7Z2H7 | cDNA FLJ58758, highly similar to Positive cofactor 2glutamine/Q-rich-associated protein; | NULL | NP_001280166.1; | 722 | human |
| Q19UK5 | Coagulation factor IX; Fragment; | F9; | NULL | 43 | human |
| A8K332 | cDNA FLJ76099; | NULL | NULL | 489 | human |
| A8K2F4 | cDNA FLJ75620; | NULL | NULL | 755 | human |
| B7Z3J7 | cDNA FLJ54358, highly similar to Homo sapiens related to CPSF subunits 74 kDa (RC74), mRNA; | NULL | NULL | 503 | human |
| B7Z4H2 | cDNA FLJ50577, highly similar to Discs large homolog 4; | NULL | NULL | 664 | human |
| B7Z8I9 | cDNA FLJ54975; | NULL | NULL | 145 | human |
| B4DHU5 | cDNA FLJ52495, highly similar to Calponin-2; | NULL | NULL | 284 | human |
| B8Y6A3 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| B7Z2S6 | cDNA FLJ55054; | NULL | NULL | 777 | human |
| Q05DD5 | CCDC55 protein; Fragment; | CCDC55; | NULL | 353 | human |
| B7ZW47 | Family with sequence similarity 25, member C; | FAM25C; | NULL | 89 | human |
| B7ZMB5 | FAM149A protein; | FAM149A; | NULL | 481 | human |
| B9X247 | MHC class I antigen; Fragment; | HLA-A; | NULL | 180 | human |
| A8K4T3 | cDNA FLJ77716, highly similar to Homo sapiens Zwilch, kinetochore associated, homolog (Drosophila), mRNA; | NULL | NP_001274752.1; | 477 | human |
| C5IZN9 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| A8K800 | cDNA FLJ76924, highly similar to Homo sapiens brix domain containing 1 (BXDC1), mRNA; | NULL | NULL | 306 | human |
| E5RHB8 | Vacuolar protein sorting-associated protein 37A; | VPS37A; | NULL | 76 | human |
| B7Z3S6 | cDNA FLJ53797, highly similar to Chordin; | NULL | NULL | 344 | human |
| B7ZW04 | PRAME family member 9; | PRAMEF9; | NULL | 478 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |